Memorial Sloan Kettering Cancer Center Statement on Affirmative Action


“The recent ruling by the Supreme Court in the cases of Students for Fair Admissions Inc. v. President and Fellows of Harvard College and Students for Fair Admissions Inc. v. University of North Carolina regarding race-conscious admissions programs will impact how institutions of higher education are permitted to make admissions decisions. This extends to academic medical centers such as Memorial Sloan Kettering Cancer Center (MSK). In anticipation of the Court’s decision, MSK has been conducting a review of potentially relevant programs and activities to assess whether updates are necessary regarding certain admissions practices. However, the implementation of any changes as required by the Court does not change or impact MSK’s unwavering commitment to diversity.

As an institution dedicated to ending cancer and improving care through research and education, MSK values diversity as a key component in achieving our mission. We succeed when diversity thrives, and we recognize that a diverse community of students, faculty, and staff brings a variety of perspectives and experiences that enrich our educational and research programs. That is why we actively prioritize diversity and inclusion efforts to recruit, retain, and develop diverse talent to create a workforce that reflects all populations we serve. Our internal policies, practices, and norms are also shaped to give everyone equal opportunities to thrive, and we hold ourselves accountable for making change.

As we continue to educate and train the next generation of world-renowned cancer researchers, scientists, and doctors, we remain focused on prioritizing diversity among our graduate student population and at the doctoral level and beyond, recognizing that a diverse workforce is essential to advancing cancer care and ultimately, improving the lives of all patients.”